132 related articles for article (PubMed ID: 38049556)
1. Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study.
Tsuruda KM; Hoff SR; Akslen LA; Hofvind S
Br J Cancer; 2024 Jan; 130(1):99-107. PubMed ID: 38049556
[TBL] [Abstract][Full Text] [Related]
2. Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review.
Tsuruda KM; Hovda T; Bhargava S; Veierød MB; Hofvind S
Eur Radiol; 2021 May; 31(5):2677-2686. PubMed ID: 33180162
[TBL] [Abstract][Full Text] [Related]
3. Prolonged screening interval due to the COVID-19 pandemic and its association with tumor characteristics and treatment; a register-based study from BreastScreen Norway.
Eijkelboom AH; Larsen M; Siesling S; Nygård JF; Hofvind S; de Munck L
Prev Med; 2023 Oct; 175():107723. PubMed ID: 37820746
[TBL] [Abstract][Full Text] [Related]
4. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
[TBL] [Abstract][Full Text] [Related]
5. Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway.
Thy JE; Vigeland E; Larsen M; Hofvind S
J Med Screen; 2022 Sep; 29(3):178-184. PubMed ID: 35502849
[TBL] [Abstract][Full Text] [Related]
6. Early screening outcomes among non-immigrants and immigrants targeted by BreastScreen Norway, 2010-2019.
Thy JE; Bhargava S; Larsen M; Akslen LA; Hofvind S
Scand J Public Health; 2023 May; 51(3):403-411. PubMed ID: 35361004
[TBL] [Abstract][Full Text] [Related]
7. Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.
Bhargava S; Akslen LA; Bukholm IRK; Hofvind S
Eur Radiol; 2019 Sep; 29(9):4833-4842. PubMed ID: 30762109
[TBL] [Abstract][Full Text] [Related]
8. Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway.
Hovda T; Holen ÅS; Lång K; Albertsen JL; Bjørndal H; Brandal SHB; Sahlberg KK; Skaane P; Suhrke P; Hofvind S
Radiology; 2020 Feb; 294(2):256-264. PubMed ID: 31821118
[TBL] [Abstract][Full Text] [Related]
9. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases.
Koch HW; Larsen M; Bartsch H; Kurz KD; Hofvind S
Eur Radiol; 2023 May; 33(5):3735-3743. PubMed ID: 36917260
[TBL] [Abstract][Full Text] [Related]
12. The financial impact of a breast cancer detected within and outside of screening: lessons from the Australian Lifepool cohort.
Saxby K; Nickson C; Mann GB; Velentzis L; Bromley HL; Procopio P; Canfell K; Petrie D
Aust N Z J Public Health; 2020 Jun; 44(3):219-226. PubMed ID: 32311194
[TBL] [Abstract][Full Text] [Related]
13. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
[TBL] [Abstract][Full Text] [Related]
14. Automated Volumetric Analysis of Mammographic Density in a Screening Setting: Worse Outcomes for Women with Dense Breasts.
Moshina N; Sebuødegård S; Lee CI; Akslen LA; Tsuruda KM; Elmore JG; Hofvind S
Radiology; 2018 Aug; 288(2):343-352. PubMed ID: 29944088
[TBL] [Abstract][Full Text] [Related]
15. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
Moshina N; Backmann HA; Skaane P; Hofvind S
Eur Radiol; 2023 Nov; ():. PubMed ID: 37935848
[TBL] [Abstract][Full Text] [Related]
16. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
17. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
Tsuruda KM; Larsen M; Román M; Hofvind S
Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
[TBL] [Abstract][Full Text] [Related]
18. The incidence and 10-year survival of interval breast cancers in Wales.
Fong Y; Evans J; Brook D; Kenkre J; Jarvis P; Gower Thomas K
Clin Radiol; 2014 Apr; 69(4):e168-72. PubMed ID: 24457014
[TBL] [Abstract][Full Text] [Related]
19. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
[TBL] [Abstract][Full Text] [Related]
20. Screening at stationary versus mobile units in BreastScreen Norway.
Holen Å; Sebuødegård S; Waade GG; Aase H; Hopland NM; Pedersen K; Larsen M; Tsuruda KM; Hofvind S
J Med Screen; 2020 Mar; 27(1):31-39. PubMed ID: 31554445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
